IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
